Approaches to Assessment of Overall Survival in Oncology Clinical Trials: Draft Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
August 19, 2025
August 18, 2025
58214f23-534c-4277-9edd-e5f553d63680
Related Documents
Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products: Draft Guidance for Industry
Guidance DocumentJanuary 9, 2026Center for Drug Evaluation and Research
Postmarketing Approaches to Obtain Data on Populations Underrepresented in Clinical Trials for Drugs and Biological Products
Guidance DocumentAugust 10, 2023Office of the Commissioner
Clinical Trial Considerations to Support Accelerated Approval of Oncology Therapeutics
Guidance DocumentMarch 24, 2023Office of the Commissioner
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.